Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 5 studies | 24% ± 7% | |
naive B cell | 5 studies | 16% ± 1% | |
epithelial cell | 4 studies | 23% ± 5% | |
microglial cell | 3 studies | 24% ± 2% | |
B cell | 3 studies | 15% ± 0% | |
GABAergic neuron | 3 studies | 47% ± 6% | |
glutamatergic neuron | 3 studies | 53% ± 8% | |
T cell | 3 studies | 16% ± 1% | |
macrophage | 3 studies | 22% ± 4% | |
astrocyte | 3 studies | 29% ± 5% | |
oligodendrocyte | 3 studies | 21% ± 1% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 926.15 | 1445 / 1445 | 100% | 14.16 | 183 / 183 |
lung | 100% | 1301.26 | 578 / 578 | 100% | 11.09 | 1152 / 1155 |
ovary | 100% | 1411.01 | 180 / 180 | 99% | 8.34 | 427 / 430 |
breast | 100% | 1359.83 | 459 / 459 | 99% | 11.72 | 1107 / 1118 |
thymus | 100% | 1348.34 | 653 / 653 | 99% | 10.33 | 599 / 605 |
brain | 98% | 721.54 | 2601 / 2642 | 100% | 11.86 | 705 / 705 |
stomach | 100% | 777.97 | 359 / 359 | 98% | 10.56 | 280 / 286 |
uterus | 100% | 1287.21 | 170 / 170 | 98% | 8.99 | 449 / 459 |
bladder | 100% | 1223.19 | 21 / 21 | 97% | 8.19 | 491 / 504 |
intestine | 100% | 1104.91 | 966 / 966 | 97% | 8.64 | 512 / 527 |
pancreas | 98% | 521.25 | 323 / 328 | 98% | 8.47 | 175 / 178 |
prostate | 100% | 1082.84 | 245 / 245 | 96% | 7.92 | 484 / 502 |
skin | 100% | 1396.09 | 1809 / 1809 | 95% | 11.73 | 450 / 472 |
kidney | 100% | 719.79 | 89 / 89 | 94% | 8.31 | 846 / 901 |
adrenal gland | 100% | 957.98 | 258 / 258 | 90% | 5.95 | 208 / 230 |
liver | 100% | 470.42 | 226 / 226 | 73% | 3.41 | 295 / 406 |
adipose | 100% | 1300.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1014.98 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.97 | 29 / 29 |
spleen | 100% | 1674.81 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 529.57 | 797 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 9.34 | 44 / 45 |
heart | 97% | 594.09 | 836 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1238.30 | 856 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 75% | 4.75 | 60 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0044843 | Biological process | cell cycle G1/S phase transition |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0001701 | Biological process | in utero embryonic development |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0015030 | Cellular component | Cajal body |
GO_0097504 | Cellular component | Gemini of coiled bodies |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003712 | Molecular function | transcription coregulator activity |
Gene name | NPAT |
Protein name | Nuclear protein, ataxia-telangiectasia locus Protein NPAT (Nuclear protein of the ataxia telangiectasia mutated locus) (Nuclear protein of the ATM locus) (p220) Nuclear protein, coactivator of histone transcription |
Synonyms | CAND3 E14 |
Description | FUNCTION: Required for progression through the G1 and S phases of the cell cycle and for S phase entry. Activates transcription of the histone H2A, histone H2B, histone H3 and histone H4 genes in conjunction with MIZF. Also positively regulates the ATM, MIZF and PRKDC promoters. Transcriptional activation may be accomplished at least in part by the recruitment of the NuA4 histone acetyltransferase (HAT) complex to target gene promoters. . |
Accessions | ENST00000278612.9 B9EG70 Q14207 H0YET3 ENST00000527296.1 E9PKJ1 ENST00000531384.1 |